Navigation Links
'License to kill' enables powerful immune attack cells in mice

Scientists have discovered that a group of important immune system cells has a surprising resemblance to cinematic British superspy James Bond: the cells receive a "license" that allows them to unleash their most potent attacks on enemies.

This licensing process apparently helps reduce the chances that the cells will erroneously direct their firepower at the body's own tissues, according to researchers at Washington University School of Medicine in St. Louis. The process is very different from other previously identified ways that help immune cells distinguish invaders from self, and could have important implications for doctors struggling to understand such issues as persistent viral infections and patients' responses to bone marrow transplants. The findings will appear in the August 4 issue of Nature.

The immune cells in question already evoked cinematic connections simply by virtue of one of their names: scientists commonly refer to them as natural killer cells. The cells rapidly attack invaders and are continually generated in the bone marrow, leading to replacement of the entire population approximately once a week.

Scientists led by Wayne M. Yokoyama, M.D., the Sam J. Levin and Audrey Loew Levin Professor of Research in Arthritis, and professor of medicine and of pathology and immunology, discovered through experiments in mice that the arsenals of natural killer cells only become fully armed after a receptor on their surfaces interacts with a molecule on the surfaces of other cells.

The molecular details of the process were so unusual that Yokoyama and his colleagues found themselves struggling to develop terms to describe it to other immunologists.

"So many other terms that might have been appropriate--education, tolerance, instruction, selection--already have specialized meanings in immunology that really aren't appropriate for this unique process we've discovered," says Yokoyama, who is a Howard Hughes Medical Institut
'"/>

Source:Washington University School of Medicine


Page: 1 2 3

Related biology news :

1. Modification of program enables prediction of gene transcription
2. World-first technology enables study of ancient bacteria
3. Novel protein complex enables survival in hostile environment
4. New method enables gene disruption in destructive fungal pathogen
5. New technology enables faster, more efficient cell harvest: Cell therapy meeting study
6. Prototype just-in-time medical device enables untrained bystanders to save lives
7. Protein enables discovery of quantum effect in photosynthesis
8. New drug shows promise as powerful anticancer agent
9. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
10. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer
11. A more powerful and efficient engine for rice: the C3-C4 challenge
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: License kill enables powerful immune attack cells mice

(Date:6/16/2015)... QUEBEC CITY , June 16, 2015 /CNW ... announce their partnership centralized around the incorporation of ... mobile point-of-care diagnostic laboratory, the Mo-POD™. This unprecedented ... the BIO International Conference at the ... from June 15 th to ...
(Date:6/15/2015)... According to a new market ... Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & ... MarketsandMarkets, The Natural Language Processing Market is expected to ... for the forecast period 2015-2020. Browse ... igures spread   through 155 P ages and ...
(Date:6/11/2015)... June 11, 2015 Daon, a global ... that its IdentityX Mobile Authentication Platform v4.0 has ... Alliance is an industry consortium launched in 2013 ... simpler, stronger authentication.  In order to receive certification, ... rigorous series of tests that measure compliance and ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2
... are working to improve understanding about obesity and cancer. ... Applied Physiology, Nutrition, and Metabolism , is the first ... than estimates like body mass index (BMI) or waist ... cancer risk in aging populations. Findings emphasize the negative ...
... publishes "Assessing Dangerous Climate Change: Required Reductions of Carbon ... from James Hansen and colleagues, and announces call for ... Research article assesses climate impacts of global warming using ... energy imbalance and simple representations of the global carbon ...
... edges of most public forests in Oregon and Washington more ... the U.S. Forest Service Pacific,s Northwest (PNW) Research Station has ... structures at the fringes of public forests, is the first ... and after the enactment of land use laws. The findings ...
Cached Biology News:Radiographic imaging exposes relationship between obesity and cancer 2Assessing dangerous climate change and call for climate change response papers 2Development near Oregon, Washington public forests 2
(Date:7/1/2015)... IN (PRWEB) , ... July 01, 2015 , ... Apex ... 2015 BIO International Convention in Philadelphia, PA. , The presentation took place ... and outlined the plans for the development of APX3330 for the treatment of pancreatic ...
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... 12 to take part in the first half of “Integrative Biotechnology,” an applied ... partnership established in summer 2014, this course combines students from both universities and ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... hosting a webinar to provide advanced scientific research into new classes of Nanoscale ... and energy. Touted as 'the wonder material of the 21st Century' by ...
Breaking Biology Technology:Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4
... announced today the availability of the world,s first clinical guidelines to ... cells to treat disease. , ... Broomfield, CO (PRWEB) ... ASCTA ) announced today the availability of the world,s first clinical ...
... illustrate potential cost effective approach for, ... Symbol: RVX,CALGARY and ATLANTA, May 19 /PRNewswire-FirstCall/ - ... pleased to announce today that it has made ... (R&D) program for inflammatory diseases. Two new patent ...
... Therapeutic for IBD with Novel Mode of ActionMOUNTAIN ... Inc., today announced that data from the company,s ... Crohn,s disease Trial) Phase II/III clinical trial of ... will be presented in an oral session at ...
Cached Biology Technology:Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices) 2Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices) 3Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices) 4Resverlogix's Success in Inflammation Program Results in 2 Patents Filed 2Resverlogix's Success in Inflammation Program Results in 2 Patents Filed 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5
Mouse monoclonal antibody raised against a partial recombinant ACTN4. NCBI Entrez Gene ID = ACTN4...
Rabbit polyclonal antibody to GluR2...
... Blocker Array II can be used to ... various proteins and sera that are commonly ... The array contains spots for 19 different ... Determination of antibody crossreactivity and species specificity, ...
... sufficient materials for 1,464 array sample elements. , ... , Blocker BSA in PBS (10X): 50 ... 10 g , BupH Phosphate Buffered ... 2 x 10 ml ampules , SuperSignal West ...
Biology Products: